Skip to main
SPRY

SPRY Market Capitalization Overview

Market Cap: $1.30B as of Jan 9, 2026

$1.30B
$309.40M (31.52%)past month
As of Jan 9, 2026, SPRY has a market capitalization of $1.30B. Over the past 30 days, its market cap has increased by 22.23%, while in the last 12 months, it has increased by 12.1%.

Market capitalization represents the total value of ARS Pharmaceuticals Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

SPRY Market Cap Formula = Stock Price * Shares Outstanding

The market cap of SPRY helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

SPRY Market Cap History

DateMarket CapChange
Dec 1, 2025$929.18M+9.07%
Nov 3, 2025$851.89M-14.57%
Oct 1, 2025$997.16M-9.26%
Sep 2, 2025$1.10B-34.87%
Aug 1, 2025$1.69B+6.77%
Jul 1, 2025$1.59B+11.27%
Jun 2, 2025$1.43B+2.22%
May 1, 2025$1.39B+13.01%
Apr 1, 2025$1.23B+24.27%
Mar 3, 2025$989.35M-17.30%
Feb 3, 2025$1.20B+14.94%
Jan 2, 2025$1.05B-19.59%

SPRY End of Year Market Cap History

DateMarket CapChange
2026$1.30B+12.10%
2025$1.16B+12.32%
2024$1.03B+94.90%
2023$526.07M+71.04%
2022$307.58M+31.66%
2021$233.61M

FAQs About ARS Pharmaceuticals Inc (SPRY) Market Cap

As of Jan 9, 2026, the market capitalization of SPRY is $1.30B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, ARS Pharmaceuticals Inc’s market capitalization has increased by 31.52%, changing from $981.57M to $1.30B as of Jan 9, 2026.

In the last 3 months, ARS Pharmaceuticals Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, ARS Pharmaceuticals Inc’s market capitalization increased from $1.03B in January to $1.16B in December, reflecting a 12.32% change.

In the past five years, SPRY has had a compound annual growth rate (CAGR) of 37.58% in market capitalization. This means its market cap has grown at an average rate of 37.58% per year.

ARS Pharmaceuticals Inc (SPRY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.